Hyperglycemia at admission independently linked to mortality in aneurysmal subarachnoid haemorrhage
Elevated blood glucose is not only linked to diabetes but is associated with increased morbidity and mortality in number of diseases.
According to a new study, among patients with aneurysmal subarachnoid haemorrhage, hyperglycemia at admission was independently associated with increased mortality.
The study has been published in the Journal of Clinical Neuroscience.
Elevated blood glucose is frequently detected early after aneurysmal subarachnoid haemorrhage (aSAH). The researchers aimed to investigate whether hyperglycemia at admission is associated with mortality in patients with aneurysmal subarachnoid haemorrhage.
In a multicenter observational study of patients with aneurysmal subarachnoid haemorrhage, we defined normal glycemia, mild hyperglycemia, moderate hyperglycemia, and severe hyperglycemia as a blood glucose of 4.00-6.09 mmol/L, 6.10-7.80 mmol/L, 7.81-10.00 mmol/L, and > 10.00 mmol/L, respectively. They performed propensity score matching to obtain the adjusted odds ratios (OR) with 95 % confidence intervals (CI).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.